European Society for Medical Oncology Congress

The latest news from ESMO, including researcher interviews and physician perspective.


Meeting News

Use of targeted treatments for advanced cancer increasing in community setting

October 19, 2018
MUNICH — Nearly one-quarter of patients with metastatic cancer who underwent comprehensive genomic profiling at National Comprehensive Cancer…

Seven important updates from European Society for Medical Oncology Congress

September 28, 2017
This year’s European Society for Medical Oncology Congress, held Sept. 8-12 in Madrid, featured the theme, “Integrating science into…
Meeting News

Pembrolizumab shows promise in metastatic head and neck cancer

September 11, 2017
MADRID — Pembrolizumab significantly reduced the risk for death compared with chemotherapy among patients with recurrent or metastatic head and…
Meeting News

Cabozantinib extends PFS as first-line therapy for metastatic renal cell carcinoma

September 11, 2017
MADRID — Cabozantinib significantly extended PFS compared with sunitinib as initial targeted therapy for patients with metastatic renal cell…
Meeting News

Adjuvant vemurafenib confers clinical benefit in resected BRAF V600-positive melanoma

September 11, 2017
MADRID — Adjuvant vemurafenib conferred substantial clinical benefit to patients with completely resected stage IIC to stage IIIB BRAF
Meeting News

Dabrafenib-trametinib combination doubles RFS in resected stage III melanoma

September 11, 2017
MADRID — Adjuvant treatment with dabrafenib and trametinib doubled RFS compared with placebo among patients with resected stage III…
Meeting NewsPerspective

Nivolumab superior to ipilimumab for adjuvant treatment of surgically resected melanoma

September 11, 2017
MADRID — Adjuvant treatment with nivolumab significantly prolonged RFS compared with standard ipilimumab for patients with surgically resected…
Meeting News

Pembrolizumab extends survival in urothelial cancer

September 10, 2017
MADRID — Pembrolizumab significantly prolonged median OS compared with chemotherapy among patients with recurrent, advanced urothelial cancer…
Meeting News

Reproductive potential can be maintained after ovarian tissue transplant

September 10, 2017
MADRID — Ovarian tissue preservation, subsequent transplantation and maintenance of reproductive potential may be feasible for women with…
Meeting NewsPerspective

Concomitant chemoradiation should be standard for locally advanced cervical cancer

September 10, 2017
MADRID — Neoadjuvant chemotherapy followed by radical surgery did not improve outcomes compared with cisplatin-based concurrent chemoradiation…